Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα‐2b and topical imiquimod 5% cream
2009; Wiley; Volume: 48; Issue: 2 Linguagem: Inglês
10.1111/j.1365-4632.2009.03576.x
ISSN1365-4632
AutoresAyşegül Turan, Hayriye Sarıcaoğlu, Emel Bülbül Başkan, Semra Çıkman Toker, Şükran Tunalı,
Tópico(s)Polyomavirus and related diseases
ResumoInternational Journal of DermatologyVolume 48, Issue 2 p. 214-215 Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα-2b and topical imiquimod 5% cream Aysegul Turan MD, Aysegul Turan MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorHayriye Saricaoglu MD, Hayriye Saricaoglu MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorEmel Bulbul Baskan MD, Emel Bulbul Baskan MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorSemra Cikman Toker MD, Semra Cikman Toker MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorSukran Tunali MD, Sukran Tunali MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this author Aysegul Turan MD, Aysegul Turan MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorHayriye Saricaoglu MD, Hayriye Saricaoglu MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorEmel Bulbul Baskan MD, Emel Bulbul Baskan MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorSemra Cikman Toker MD, Semra Cikman Toker MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this authorSukran Tunali MD, Sukran Tunali MD Department of Dermatology, Uludag University Medical Faculty, Bursa, TurkeySearch for more papers by this author First published: 19 January 2009 https://doi.org/10.1111/j.1365-4632.2009.03576.xCitations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Drake LA, Ceilley RI, Cornelison RL, et al . Guidelines of care for basal cell carcinoma. J Am Acad Dermatol 1992; 26: 117–120. 2 Cornell RC, Greenway HT, Tucker SB, et al . Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23 (4 Part 1): 694–700. 3 Buechner S, Wernli M, Bachmann F, et al . Intralesional interferon in basal cell carcinoma: how does it work? Recent Results Cancer Res 2002; 160: 246–250. 4 Testerman TL, Gerster JF, Imbertson LM, et al . Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995; 58: 365–372. 5 Shumack S, Robinson J, Kossard S, et al . Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma. Comparison of dosing regimens. Arch Dermatol 2002; 138: 1165–1171. 6 Sterry W, Ruzicka T, Herrera E, et al . Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227–1236. 7 Geisse J, Caro I, Lindholm J, et al . Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722–733. 8 Vidal D, Matias-Guiu X, Alomar A. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Exp Dermatol 2004; 29: 518–525. 9 Kim KH, Yavel RM, Gross VL, et al . Intralesional interferon α-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited. Dermatol Surg 2004; 30: 116–120. 10 Greenway HT, Cornell RC, Tanner DJ, et al . Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 1986; 15: 437–443. Citing Literature Volume48, Issue2February 2009Pages 214-215 ReferencesRelatedInformation
Referência(s)